A point mutation at the ATP‐binding site of the EGF‐receptor abolishes signal transduction.
Year: 1988
Type: article
Source: The EMBO Journal
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institutes of Health
OpenAlex ID: W150641858
